| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 146.414 | 80 |
| GSM780708 | Untreated after 4 days (C2_1) | 143.652 | 80 |
| GSM780709 | Untreated after 4 days (C3_1) | 118.428 | 78 |
| GSM780719 | Untreated after 4 days (C1_2) | 151.167 | 81 |
| GSM780720 | Untreated after 4 days (C2_2) | 169.567 | 82 |
| GSM780721 | Untreated after 4 days (C3_2) | 143.677 | 80 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 145.054 | 80 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 157.108 | 81 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 147.696 | 80 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 170.901 | 82 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 138.287 | 79 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 148.427 | 80 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 133.278 | 79 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 140.76 | 80 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 155.72 | 81 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 155.33 | 81 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 148.288 | 80 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 132.052 | 79 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 195.356 | 83 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 158.883 | 81 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 148.181 | 80 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 179.75 | 82 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 164.681 | 81 |